Say it LOUD for the people in the back...
“HAPPY 7 YEARS, JEUVEAU®!”
We’re celebrating our lucky number 7 with some of our favorite partners (@faycedbyfay@drarielostad@mariehayagmd@libbbymaritza ) that keep pushing us forward, like you—the artists, the innovators, the ones redefining what beauty looks like each and every day.
Because everyone is a winner when you choose Jeuveau.
For full Prescribing Information, including Boxed Warning and Medication Guide, see @jeuveaubyevoluspi or visit evolusrx.com
Jeuveau® (prabotulinumtoxinA-xvfs) is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
The effects of all botulinum toxin products, including Jeuveau, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. Jeuveau is not approved for the treatment of spasticity or any conditions other than glabellar lines.
Do not use Jeuveau in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, and in the presence of infection at the proposed injection site.
See full Prescribing Information for complete product information.
Rx Only
For US Healthcare Professionals
US-JUV-2600158
A look back at last week’s ICON experience in the UK with @evolusacademy , centered on peer-to-peer connection and advancing techniques that deliver the outcomes patients are asking for.
This experience was designed to bring together modern aesthetic leaders to exchange expertise, spark new ideas, and push performance beauty forward. From meaningful partnership moments to elevated education, every detail was created with our customers in mind.
Connecting peers across the pond, exploring emerging trends, and redefining how we collaborate — this is partnership in action.
Interested in these exclusive, one-of-a-kind ICON Experiences with Evolus Academy? Contact your Evolus Rep to learn more.
US-UNB-2600063
Big news: Jeuveau® won the 2025 @Shape Award! 🏆
Recognized for its fast-acting*, long-lasting** results, Jeuveau is the first frown line treatment created exclusively for aesthetics.
✔ Visible results starting in as little as 2 days*
✔ Lasts up to 4 months**
✔ Highly recommended by patients***
Jeuveau is proud to take home the win!
Visit Jeuveau.com to learn more.
#jeuveau #evolus #choosejeuveau #performancebeauty #beautyawards #awardwinning
For full Product Information, including Boxed Warning and Medication Guide, see @jeuveaubyevoluspi or visit evolusrx.com
Jeuveau® (prabotulinumtoxinA-xvfs) is an FDA-approved prescription injectable treatment used to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults.
There are risks with treatment ‒ effects of Jeuveau may spread hours to weeks after injection causing serious symptoms. Alert your doctor right away of difficulty swallowing, speaking, breathing, eye problems or muscle weakness, which can be signs of a life-threatening condition. Other serious risks include allergic reactions, heart or eye problems. The most common side effects are headache, eyelid drooping, upper respiratory infection, and increased white blood cell count.
Ask your doctor about Jeuveau and whether it’s right for you.
*About 50% of patients begin showing improvement after two days. Most patients (~69%) achieve complete results by day 30.
**On average, Jeuveau patients receive three treatments per year.
***Consumer Pulse Survey 2024, Data on file. (N=424). 9 out of 10 people treated with Jeuveau would recommend it to a friend or family member.
Intended for US audiences only.
US-JUV-2500612
It’s been 7 years of smoother frown lines, and to mark this milestone we’re celebrating with some of our esteemed partners.
You are the heartbeat of what makes Jeuveau® stand out and the inspiration for a world where practices and patients keep coming back for more.
“Seven years ago, I was one of the first adopters of Jeuveau...I knew that it would work well for myself and my patients.” - @mariehayagmd Board-Certified Dermatologist, New York
For full Prescribing Information, including Boxed Warning and Medication Guide, see @jeuveaubyevoluspi or visit evolusrx.com
Jeuveau® (prabotulinumtoxinA-xvfs) is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
The effects of all botulinum toxin products, including Jeuveau, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. Jeuveau is not approved for the treatment of spasticity or any conditions other than glabellar lines.
Do not use Jeuveau in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, and in the presence of infection at the proposed injection site.
See full Prescribing Information for complete product information.
Rx Only
For US Healthcare Professionals
US-JUV-2600157
We’re heading northeast to bean town for The Aesthetic Society’s big event!
Check us out at ASAPS and stop by to learn about the latest in modern aesthetics, performance beauty, and all the innovations Evolus is advancing—we’d love to see you there!
🗓️ May 14-17, 2026
📍 Boston, MA
US-UNB-2600116
It’s Jeuveau’s 7th anniversary, and it’s time to go all in! ️️♣️ 🃏
Made for winners, it’s clear why we’re always the house favorite:
🎲 A smart bet for smoothing frown lines.
🎲 A quick pick for fast-acting results.*
🎲 A sure thing for long-lasting performance.†
Hit the jackpot. Choose Jeuveau®.
Celebrate with us—click the link in bio to learn more.
For full Product Information, including Boxed Warning and Medication Guide, see @jeuveaubyevoluspi or visit evolusrx.com
Jeuveau® (prabotulinumtoxinA-xvfs) is an FDA-approved prescription injectable treatment used to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults.
There are risks with treatment ‒ effects of Jeuveau may spread hours to weeks after injection causing serious symptoms. Alert your doctor right away of difficulty swallowing, speaking, breathing, eye problems or muscle weakness, which can be signs of a life-threatening condition. Other serious risks include allergic reactions, heart or eye problems. The most common side effects are headache, eyelid drooping, upper respiratory infection, and increased white blood cell count.
Ask your doctor about Jeuveau and whether it’s right for you.
*About 50% of patients begin showing improvement after two days. Most patients (~69%) achieve complete results by day 30.
†On average, Jeuveau patients receive three treatments per year.
Intended for US audiences only.
US-JUV-2600127
Vanessa Lee
RN and founder of @thethingswedo.co
DTLA, Venice, Chino Hills, and Honolulu
In this industry, your’e always the student. And at @evolusacademy , we embrace that.
Vanessa Lee (@vanessalee_rn ) believes education and learning is an important part of the job. ”It’s extremely important to learn about the newer innovation. about the new science, and about cutting-edge things within our industry because you don’t want to be left behind and you want to have best-in-class to offer your patients at your businesses.”
Stay tuned to hear more from our esteemed partners appearing in our Spotlight Series.
US-UNB-2600155
Made for winners... 🎰
Jeuveau® is celebrating 7 years in aesthetics, and we’re going all in.
Celebrate this milestone with an opportunity for limited-edition scrubs and $80 OFF Evolus Rewards™!
Because when it comes to smoothing frown lines between the brows, Jeuveau is always a smart bet.
Contact your rep to learn more.
For full Prescribing Information, including Boxed Warning and Medication Guide, see @jeuveaubyevoluspi or visit evolusrx.com
Jeuveau® (prabotulinumtoxinA-xvfs) is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
The effects of all botulinum toxin products, including Jeuveau, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. Jeuveau is not approved for the treatment of spasticity or any conditions other than glabellar lines.
Do not use Jeuveau in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, and in the presence of infection at the proposed injection site.
See full Prescribing Information for complete product information.
Rx Only
For US Healthcare Professionals
US-JUV-2600130
Calling all SoCal Creators… 📣 ✨
Come visit our headquarters in sunny Newport Beach, CA for an exclusive, VIP event curated to local creators, like you!
Sunday, June 7
10 - 4PM
Lite bites, Beauty Swag Bags…and so much more!
Interested?
We only have a few spots available, click the link in bio to be considered!
US-UNB-2600157
Feeling lucky? 😉
For 7 years, Jeuveau® has been a sure bet for patients looking to smooth frown lines.
Stay tuned for a big reveal on May 11th, because we’re about to go all in on this celebration...
For full Prescribing Information, including Boxed Warning and Medication Guide, see @jeuveaubyevoluspi or visit evolusrx.com
Jeuveau® (prabotulinumtoxinA-xvfs) is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
The effects of all botulinum toxin products, including Jeuveau, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. Jeuveau is not approved for the treatment of spasticity or any conditions other than glabellar lines.
Do not use Jeuveau in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, and in the presence of infection at the proposed injection site.
See full Prescribing Information for complete product information.
Rx Only
For US Healthcare Professionals
US-JUV-2600129
Dr. Mary Lupo, MD
Board-Certified Dermatologist
New Orleans, LA
“Jeuveau® is different. When my patients try it, they really like it...and they keep on wanting it.”
Trusted by experienced dermatologists like Dr. Lupo of @lupo_dermatology , Jeuveau continues to be a go-to choice for:
✔️ Proven clinical performance
✔️ High patient satisfaction*
Proud to partner with world-renown providers, advancing aesthetic medicine every day.
For full Prescribing Information, including Boxed Warning and Medication Guide, see @jeuveaubyevoluspi or visit evolusrx.com
Jeuveau® (prabotulinumtoxinA-xvfs) is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
The effects of all botulinum toxin products, including Jeuveau, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. Jeuveau is not approved for the treatment of spasticity or any conditions other than glabellar lines.
Do not use Jeuveau in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, and in the presence of infection at the proposed injection site.
See full Prescribing Information for complete product information.
*Rzany, et al., Aesthetic Surgery Journal 2020, Vol 40(4) 413–429
Rx Only
For US Healthcare Professionals
US-JUV-2600086
We’re heading straight to Nashville, y'all! 🤠
We'll be at @scalemusiccity for the Premier Medical & Cosmetic Dermatology Event, showcasing everything that Evolus has been up to from performance beauty to innovations within the industry.
See you there!
🗓️ May 13-16, 2026
📍 Grand Hyatt Nashville, Nashville, TN
US-UNB-2600089
